Crossmark

Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting

Crossref DOI link: https://doi.org/10.1016/j.htct.2026.106436

Published Print: 2026-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Gutierrez-Aguirre, Cesar Homero https://orcid.org/0000-0002-9876-3633
la Garza-Salazar, Fernando De https://orcid.org/0000-0003-0080-487X
Gómez-Almaguer, David https://orcid.org/0000-0002-0460-6427
Jaime-Pérez, José Carlos https://orcid.org/0000-0001-6804-9095
Mancias-Guerra, María del Consuelo https://orcid.org/0000-0003-4292-8635
León, Andrés Gómez-de https://orcid.org/0000-0001-6904-9345
Colunga-Pedraza, Perla https://orcid.org/0000-0002-9937-439X
Mata, Mariana Jazmín Moedano

Rosales, Verónica del Carmen Estrada

Catú-Rodríguez, Olga Graciela https://orcid.org/0000-0003-2134-3734
License Information

Text and Data Mining valid from 2026-10-01

Text and Data Mining valid from 2026-10-01

Version of Record valid from 2026-02-20
More Information

This article is maintained by: Elsevier

Article Title: Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2026.106436

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U. on behalf of Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular.